United States (US) Carrier Screening Market (2025-2031) | Forecast, Industry, Analysis, Value, Companies, Growth, Segmentation, Size & Revenue, Competitive Landscape, Share, Trends, Outlook

Name: United States (US) Carrier Screening Market (2025-2031) | Forecast & Industry
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Test Type (Molecular Screening Test, Biochemical Screening Test), By Disease Type (Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy, Other Autosomal Recessive Genetic Disorders), By Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Others), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Others) And Competitive Landscape

Product Code: ETC9961910	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Carrier Screening Market Outlook
Market Size of United States (US) Carrier Screening Market, 2024
Forecast of United States (US) Carrier Screening Market, 2031
Historical Data and Forecast of United States (US) Carrier Screening Revenues & Volume for the Period 2021- 2031
United States (US) Carrier Screening Market Trend Evolution
United States (US) Carrier Screening Market Drivers and Challenges
United States (US) Carrier Screening Price Trends
United States (US) Carrier Screening Porter's Five Forces
United States (US) Carrier Screening Industry Life Cycle
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Test Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Molecular Screening Test for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Biochemical Screening Test for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Disease Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Cystic Fibrosis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Tay-Sachs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Gaucher Disease for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Sickle Cell Disease for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Spinal Muscular Atrophy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Other Autosomal Recessive Genetic Disorders for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Medical Condition for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Pulmonary Conditions for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Hematological Conditions for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Neurological Conditions for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By DNA Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Polymerase Chain Reaction for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Microarrays for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Reference Laboratories for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Physician Offices and Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Carrier Screening Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Carrier Screening Import Export Trade Statistics
Market Opportunity Assessment By Test Type
Market Opportunity Assessment By Disease Type
Market Opportunity Assessment By Medical Condition
Market Opportunity Assessment By Technology
Market Opportunity Assessment By End User
United States (US) Carrier Screening Top Companies Market Share
United States (US) Carrier Screening Competitive Benchmarking By Technical and Operational Parameters
United States (US) Carrier Screening Company Profiles
United States (US) Carrier Screening Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Carrier Screening Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Carrier Screening Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Carrier Screening Market - Industry Life Cycle

3.4 United States (US) Carrier Screening Market - Porter's Five Forces

3.5 United States (US) Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F

3.6 United States (US) Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.7 United States (US) Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F

3.8 United States (US) Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.9 United States (US) Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United States (US) Carrier Screening Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about genetic diseases and their carrier screening importance among the population

4.2.2 Growing demand for preconception genetic testing to assess the risk of passing genetic disorders to offspring

4.2.3 Technological advancements leading to the development of more accurate and cost-effective carrier screening tests

4.3 Market Restraints

4.3.1 High costs associated with carrier screening tests, limiting accessibility for some individuals

4.3.2 Ethical concerns and potential stigmatization associated with genetic testing

4.3.3 Regulatory challenges and varying insurance coverage for carrier screening tests

5 United States (US) Carrier Screening Market Trends

6 United States (US) Carrier Screening Market, By Types

6.1 United States (US) Carrier Screening Market, By Test Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Carrier Screening Market Revenues & Volume, By Test Type, 2021- 2031F

6.1.3 United States (US) Carrier Screening Market Revenues & Volume, By Molecular Screening Test, 2021- 2031F

6.1.4 United States (US) Carrier Screening Market Revenues & Volume, By Biochemical Screening Test, 2021- 2031F

6.2 United States (US) Carrier Screening Market, By Disease Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Carrier Screening Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F

6.2.3 United States (US) Carrier Screening Market Revenues & Volume, By Tay-Sachs, 2021- 2031F

6.2.4 United States (US) Carrier Screening Market Revenues & Volume, By Gaucher Disease, 2021- 2031F

6.2.5 United States (US) Carrier Screening Market Revenues & Volume, By Sickle Cell Disease, 2021- 2031F

6.2.6 United States (US) Carrier Screening Market Revenues & Volume, By Spinal Muscular Atrophy, 2021- 2031F

6.2.7 United States (US) Carrier Screening Market Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021- 2031F

6.3 United States (US) Carrier Screening Market, By Medical Condition

6.3.1 Overview and Analysis

6.3.2 United States (US) Carrier Screening Market Revenues & Volume, By Pulmonary Conditions, 2021- 2031F

6.3.3 United States (US) Carrier Screening Market Revenues & Volume, By Hematological Conditions, 2021- 2031F

6.3.4 United States (US) Carrier Screening Market Revenues & Volume, By Neurological Conditions, 2021- 2031F

6.3.5 United States (US) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Carrier Screening Market, By Technology

6.4.1 Overview and Analysis

6.4.2 United States (US) Carrier Screening Market Revenues & Volume, By DNA Sequencing, 2021- 2031F

6.4.3 United States (US) Carrier Screening Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F

6.4.4 United States (US) Carrier Screening Market Revenues & Volume, By Microarrays, 2021- 2031F

6.4.5 United States (US) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Carrier Screening Market, By End User

6.5.1 Overview and Analysis

6.5.2 United States (US) Carrier Screening Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United States (US) Carrier Screening Market Revenues & Volume, By Reference Laboratories, 2021- 2031F

6.5.4 United States (US) Carrier Screening Market Revenues & Volume, By Physician Offices and Clinics, 2021- 2031F

6.5.5 United States (US) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Carrier Screening Market Import-Export Trade Statistics

7.1 United States (US) Carrier Screening Market Export to Major Countries

7.2 United States (US) Carrier Screening Market Imports from Major Countries

8 United States (US) Carrier Screening Market Key Performance Indicators

8.1 Number of healthcare providers offering carrier screening services

8.2 Adoption rate of carrier screening tests among high-risk populations

8.3 Research and development investment in improving carrier screening technologies

9 United States (US) Carrier Screening Market - Opportunity Assessment

9.1 United States (US) Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F

9.2 United States (US) Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.3 United States (US) Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F

9.4 United States (US) Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F

9.5 United States (US) Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F

10 United States (US) Carrier Screening Market - Competitive Landscape

10.1 United States (US) Carrier Screening Market Revenue Share, By Companies, 2024

10.2 United States (US) Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Carrier Screening Market

Equatorial Guinea Carrier Screening Market

Eritrea Carrier Screening Market

Estonia Carrier Screening Market

Ethiopia Carrier Screening Market

Fiji Carrier Screening Market

Global Carrier Screening Market

Middle East Carrier Screening Market

North America Carrier Screening Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here